Back
ESC Premium Access

Different features of cardiac involvement in patients with AL vs. TTR amyloidosis

Session: Cardiac amyloidosis
Topic: Cardiomyopathies
Speaker: Doctor V. Chubuchny (Pisa, IT)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Doctor Vladyslav Chubuchny

Toscana Gabriele Monasterio Foundation, Pisa (Italy)
1 presentation
0 follower

6 more presentations in this session

Comparison of various non-invasive tools for diagnosing AL cardiac amyloidosis.

Speaker: Mr M. Nicol (Paris, FR)

Access
Abstract
Slides
Like
Thumbnail

Investigation of left ventricular function and biomarkers following treatment in patients with light-chain cardiac amyloidosis

Access
Like
Thumbnail

Predictors of progression of light-chain cardiac amyloidosis.

Speaker: Doctor V. Rameev (Moscow, RU)

Access
Abstract
Slides
Like
Thumbnail

Prognosis of patients with cardiac amyloidosis referred in the French cardiac amyloidosis expert center.

Speaker: Professor T. Damy (Creteil, FR)

Access
Abstract
Slides
Like
Thumbnail

AG10, an orally available, novel transthyretin (TTR) stabilizer: integrated preclinical evaluation predicts a highly effective treatment for TTR amyloid cardiomyopathy

Speaker: Associate Professor M. Alhamadsheh (Stockton, US)

Access
Abstract
Like
Thumbnail

Access the full session

Cardiac amyloidosis

Speakers: Doctor V. Chubuchny, Mr M. Nicol, Doctor V. Rameev, Professor T. Damy, Associate Professor M. Alhamadsheh
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources